1167 MASSACHUSETTS AVENUE, ARLINGTON, MA
Exclusive Distribution Agreement with Virotek for Genetic Testing Program
Material disclosure
Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard; Transfer of Listing
News, Legal Opinion
Announces Reverse Stock Split
Director Resignation - David Lazar Steps Down from KALA BIO, Inc. Board
CEO Resignation; David Lazar Steps Down at KALA Bio, Inc.
KALA Bio Enters into $6 Million Series AA Preferred Stock Agreement
Q2
Notice of Late Filing for Quarterly Report
FY 2025
Notice of Late Filing for Annual Report
Q3
Q1
Prospectus filed pursuant to Rule 424(b)(5)
Effectiveness Notice
Amended Registration Statement for Securities Offered under a Shelf Registration
Notice of Exempt Offering of Securities
Prospectus filed pursuant to Rule 424(b)(3)
Registration Statement for Securities Offered under a Shelf Registration
Definitive Proxy Statement
PRE 14A
Additional Proxy Materials
PRER14A
Amended Schedule 13D - Ownership Report
Amended Schedule 13G - Ownership Report
Notice of Proposed Sale of Securities
Initial Statement of Beneficial Ownership